NFE2 like bZIP transcription factor 2 mitigates NAFLD by reducing ROS production, while DLD, highly expressed in NAFLD, enhances ROS generation, exacerbating oxidative stress and NAFLD progression.156. This evidence concerns the gene NFE2L2 and metabolic dysfunction-associated steatotic liver disease.